NTNH蛋白:不仅仅是肉毒神经毒素的保
1Department of Physiology and Biophysics, University of California, Irvine, Irvine, CA, USA.
The FEBS journal
|November 27, 2023
概括
肉毒神经毒素 (BoNTs) 需要辅助蛋白质,如非有毒的非血凝素 (NTNH),以保持稳定和保护. 一项新的冷电子显微镜研究揭示了类似BoNT的复合物的结构,突出了NTNH.
科学领域:
- 微生物学 微生物学
- 结构生物学 结构生物学
- 毒理学 毒理学 毒理学
背景情况:
- 肉毒神经毒素 (BoNTs) 是一种高度致命的物质,以复杂的形式起作用.
- 非毒性非血凝素 (NTNH) 是一种与BoNTs共同分泌的关键蛋白质,形成最小原始毒素复合体 (M-PTC) 以稳定性和保护性.
研究的目的:
- 阐明微型原始毒素复合体 (M-PTC) 的结构组合,由氏菌 (Weissella oryzae) (BoNT/Wo) 产生的类似BoNT的毒素.
- 研究BoNT/Wo复合体中NTNH的结构特征,并将其与其他已知的BoNT进行比较.
主要方法:
- 使用冷电子显微镜 (cryo-EM) 来确定M-PTC/Wo.的高分辨率结构.
主要成果:
- 冷-EM结构显示,M-PTC/Wo与其他BoNT的M-PTC共享类似的组装模式.
- 确定了NTNH/Wo的独特结构特征,使其与其他BoNT复合体中的NTNH蛋白区别开来.
结论:
- 结构发现证实了BoNT原生复合体的保存组装原理.
- NTNH/Wo的独特特征表明,在中毒过程中,除了简单的稳定之外,可能有不同的作用.
- 这项研究为NTNH在BoNT相关毒素中的功能性多功能性提供了新的见解.
更多相关视频
12:25Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
Published on: March 3, 2014
16.0K
15:05Functional Evaluation of Biological Neurotoxins in Networked Cultures of Stem Cell-derived Central Nervous System Neurons
Published on: February 5, 2015
9.4K
相关概念视频
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
684
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
684
Neuromuscular Junction And Blockade
3.1K
The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
3.1K
Fusion of Secretory Vesicles with the Plasma Membrane
11.1K
Proteins and neurotransmitters in secretory vesicles can be released from a cell upon vesicle docking, priming, and fusion with the plasma membrane. Vesicles are docked and primed in preparation for the quick exocytosis of their contents in response to a stimulus. The fusion process is mainly carried out by a SNAP Receptor or SNARE complex, consisting of synaptobrevin, syntaxin-1, and SNAP-25.
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
11.1K
Cholinergic Neurons: Neurotransmission
3.0K
Cholinergic neurotransmission involves the synthesis and the release of acetylcholine (ACh) in order to transmit nerve impulses across the synapse. The process begins with the synthesis of acetyl CoA, a precursor for ACh, from ATP, acetate, and coenzyme A in the mitochondria. Choline, another vital precursor, is transported inside the neuron through choline transporters, including high-affinity choline transporter CHT1, low-affinity choline transporter CTL1, and lower-affinity choline...
3.0K
Cholinergic Receptors: Nicotinic
2.8K
Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
2.8K
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
